Search

everythinglearnresearchcommunity

for

Search:↓

Hair disorders in organ transplant patients are often underestimated and need more attention and research.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Peanut allergies can be transferred through organ transplants.

Alopecia is rare after organ transplants but more common in females, Hispanic patients, and pancreas recipients.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Organ transplants can greatly improve life but also bring challenges, requiring empathy and better communication from providers.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Transplant patients often get skin problems, with treatments varying by condition.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Renal transplant recipients often have skin issues, especially infections, and need regular skin check-ups.

Most kidney transplant patients in the study had skin problems, often related to infections, medication side effects, or skin cancer risks.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

HBM-based nursing intervention improved medication compliance, reduced negative emotions, and enhanced quality of life for renal transplant recipients.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

A rare case of a transplant patient developing a skin condition linked to HPV-49.